August 27, 2022
Clinical assessment of confirmed human monkeypox virus cases in Spain | Monkeypox Virus Infection across 16 Countries | Clinical characteristics of ambulatory and hospitalized patients with monkeypox | Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection | Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years | Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age | Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine